Select for export Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2025.110334 PubMed 39900138 Copy citation Copy BibTeX Unknown journal 2025-01-31 Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y Europe PMC Published psilocybin Receptor PharmacologyMicrodosingAnimal Study Animal Study More
Select for export Psychedelic-assisted treatment for substance use disorder: A narrative systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.16762 PubMed 39887551 Copy citation Copy BibTeX Unknown journal 2025-01-29 Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J Europe PMC Published psilocybin AddictionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2452226 PubMed 39878200 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2025-01-28 Carrie Cuttler, Amanda Stueber, Jonathan J. Simone, Leah M. Mayo OpenAlex Published psilocybin AnxietyHeadache / MigraineClinical Trial Clinical Trial More
Select for export From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-28111-3 PubMed 39881126 Copy citation Copy BibTeX Scientific Reports 2025-01-28 Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, Taylor Lyons, Fernando E. Rosas, Pedro A. M. Mediano OpenAlex Published psilocybin Brain ImagingWellbeing Other More
Select for export Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’ Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.78171 PubMed 39882198 Copy citation Copy BibTeX Cureus 2025-01-28 Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph Peill, Cyrus Rohani-Shukla, Mairead Healy OpenAlex Published psilocybin OCDChronic PainNeuroplasticity Other More
Select for export Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.5c00031 PubMed 39967620 Copy citation Copy BibTeX Unknown journal 2025-01-28 Kargbo RB. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Review Article More
Select for export Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2025.116381 PubMed 39889565 Copy citation Copy BibTeX Psychiatry Research 2025-01-28 Felix Müller, Thomas Sauer, Corina Hänny, Markus Mühlhauser, Undine E. Lang OpenAlex Published psilocybin DepressionEmotional ProcessingCase Report Case Report More
Select for export Effects of Psilocybin on Mouse Brain Microstructure Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3174/ajnr.a8634 PubMed 39880687 Copy citation Copy BibTeX American Journal of Neuroradiology 2025-01-28 Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks OpenAlex Published psilocybin DepressionBrain ImagingPharmacology Clinical Trial More
Select for export Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin No abstract availability was recorded for this entry. Details DOI 10.1016/j.ejphar.2025.177304 PubMed 39864573 Copy citation Copy BibTeX European Journal of Pharmacology 2025-01-26 James J Gattuso, Carey Wilson, Shanshan Li, Anthony J. Hannan, Thibault Renoir OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/1873-3468.15099 PubMed 39865564 Copy citation Copy BibTeX FEBS Letters 2025-01-25 Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia OpenAlex Published psilocin PharmacologyMechanism of ActionReceptor Pharmacology Other More
Select for export Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-024-06742-2 PubMed 39847068 Copy citation Copy BibTeX Unknown journal 2025-01-22 Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M Europe PMC Published psilocybin Mechanism of ActionMeta-AnalysisSystematic Review Meta-Analysis More
Select for export Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2024.00431 Copy citation Copy BibTeX Journal of Psychedelic Studies 2025-01-20 Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval OpenAlex Published psilocybin ConsciousnessSafety Other More
Select for export A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-01-19 Central Institute of Mental Health, Mannheim ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0313741 PubMed 39823496 Copy citation Copy BibTeX PLoS ONE 2025-01-16 Shakila Meshkat, Richard J. Zeifman, Kathleen E. Stewart, Reinhard Janssen-Aguilar, Wendy Lou, Rakesh Jetly OpenAlex Published psilocybin PTSDChronic PainMechanism of Action Clinical Trial More
Select for export Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/annurev-med-050423-095712 PubMed 39527720 Copy citation Copy BibTeX Unknown journal 2025-01-15 Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A. Europe PMC Published psilocybin DepressionReview ArticleTreatment-Resistant Depression Review Article More
Select for export Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40262-024-01454-4 PubMed 39812743 Copy citation Copy BibTeX Unknown journal 2025-01-14 Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE Europe PMC Published psilocybinpsilocin End-of-Life DistressPharmacologySystematic Review Systematic Review More
Select for export What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases? No abstract availability was recorded for this entry. Details DOI 10.1002/cca.4512 Copy citation Copy BibTeX Cochrane Clinical Answers 2025-01-12 Amin Sharifan OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pst0000551 PubMed 39804360 Copy citation Copy BibTeX Psychotherapy 2025-01-12 Roman Palitsky, Jessica L. Maples-Keller, Caroline Peacock, Boadie W. Dunlop, Tanja Mletzko, George H. Grant OpenAlex Published psilocybin Chronic PainClinical TrialCancer Patients Clinical Trial More
Select for export Study finds encouraging results in psilocybin treatment for TRD patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/mhw.34292 Copy citation Copy BibTeX Mental Health Weekly 2025-01-09 Valerie A. Canady OpenAlex Published psilocybin DepressionPharmacologyAging Other More
Select for export PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.51249/hs.v5i01.2377 Copy citation Copy BibTeX Health and Society 2025-01-07 Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini OpenAlex Published psilocybin DepressionPTSDNeuroplasticity Review Article More
